Financials Kusurinomadoguchi, Inc.
Equities
5592
JP3266230006
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,415 JPY | +1.80% | -1.39% | -17.78% |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Net sales 1 | 6,489 | 7,420 |
EBITDA | - | - |
EBIT 1 | 715 | 1,050 |
Operating Margin | 11.02% | 14.15% |
Earnings before Tax (EBT) 1 | 800 | 835 |
Net income 1 | 515 | 391 |
Net margin | 7.94% | 5.27% |
EPS 2 | 67.75 | 42.59 |
Free Cash Flow | - | - |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 8/30/23 | 8/30/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: March | 2024 S1 | 2024 Q3 |
---|---|---|
Net sales 1 | 4,255 | 2,004 |
EBITDA | - | - |
EBIT 1 | 842 | 259 |
Operating Margin | 19.79% | 12.92% |
Earnings before Tax (EBT) 1 | 845 | 237 |
Net income 1 | 531 | 189 |
Net margin | 12.48% | 9.43% |
EPS 2 | 57.90 | 15.89 |
Dividend per Share | - | - |
Announcement Date | 11/14/23 | 2/14/24 |
Balance Sheet Analysis
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | 5,022 | 5,946 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | - |
ROE (net income / shareholders' equity) | - | 16.6% |
ROA (Net income/ Total Assets) | - | 5.65% |
Assets 1 | - | 6,922 |
Book Value Per Share 2 | 322.0 | 294.0 |
Cash Flow per Share 2 | 661.0 | 648.0 |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 8/30/23 | 8/30/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.78% | 98.82M | |
-9.49% | 28.16B | |
+25.35% | 8.33B | |
+33.25% | 4.39B | |
-35.85% | 2.43B | |
-9.44% | 1.6B | |
-13.39% | 1.5B | |
-32.84% | 1.15B | |
+7.80% | 964M | |
-37.56% | 872M |
- Stock Market
- Equities
- 5592 Stock
- Financials Kusurinomadoguchi, Inc.